Pyrido[2,3-b]pyrazine compounds useful as IP receptor agonist
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jun 17, 2014
Grant Date -
Apr 25, 2013
app pub date -
Jul 14, 2011
filing date -
Jul 14, 2010
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The present invention provides heterocyclic derivatives which activate the IP receptor. Activating the IP receptor signaling pathway is useful to treat many forms of PAH, pulmonary fibrosis and exert beneficial effects in fibrotic conditions of various organs in animal models and in patients. Pharmaceutical compositions comprising such derivatives are also encompassed. Examples of compounds of the invention include the compounds according to Formula Ia, or a pharmaceutically acceptable salt thereof, and the compounds of the examples.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully